메뉴 건너뛰기
Journal of Hepatology
Volumn 45, Issue 2, 2006, Pages 172-173
Antiviral effect of peginterferon alfa-2b and alfa-2a compared
Author keywords

[No Author keywords available]
Indexed keywords

PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PROTEINASE INHIBITOR; RIBAVIRIN;
EID: 33745727270     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.06.003     Document Type: Editorial
Times cited : (4)
References (6)
  • 1
    • 7044236793 scopus 로고    scopus 로고
    • Review article: pegylated interferons: chemical and clinical differences
    • Foster G.R. Review article: pegylated interferons: chemical and clinical differences. Aliment Pharmacol. Ther. 20 (2004) 825-830
    • (2004) Aliment Pharmacol. Ther. , vol.20 , pp. 825-830
    • Foster, G.R.1
  • 2
    • 0041317671 scopus 로고    scopus 로고
    • Pharmacokinetics of peginterferons
    • Zeuzem S., Welsch C., and Herrmann E. Pharmacokinetics of peginterferons. Semin Liver Dis 23 Suppl. (2003) 23-28
    • (2003) Semin Liver Dis , vol.23 , Issue.SUPPL , pp. 23-28
    • Zeuzem, S.1    Welsch, C.2    Herrmann, E.3
  • 3
    • 33745696443 scopus 로고    scopus 로고
    • Cost-efficacy analysis of peginterferon alfa-2b plus ribavirin compared with interferon alfa-2a plus ribavirin for the treatment of chronic hepatitis C
    • Malone D.C., Tran T.T., and Poordad F.F. Cost-efficacy analysis of peginterferon alfa-2b plus ribavirin compared with interferon alfa-2a plus ribavirin for the treatment of chronic hepatitis C. J Manag CRE Pharm 11 (2005) 687-694
    • (2005) J Manag CRE Pharm , vol.11 , pp. 687-694
    • Malone, D.C.1    Tran, T.T.2    Poordad, F.F.3
  • 4
    • 16444364546 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a or alfa-2b with ribavirin in treatment nai{dotless}̈ve patients with genotype 1 chronic hepatitis C
    • (abstract)
    • Di Bisceglie A.M., Rustgi V.K., Tuluvath P., Davis M., Ghalib R., Lyons M.F., et al. Pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a or alfa-2b with ribavirin in treatment nai{dotless}̈ve patients with genotype 1 chronic hepatitis C. Hepatology 40 Suppl. 1 (2004) 734 (abstract)
    • (2004) Hepatology , vol.40 , Issue.SUPPL. 1 , pp. 734
    • Di Bisceglie, A.M.1    Rustgi, V.K.2    Tuluvath, P.3    Davis, M.4    Ghalib, R.5    Lyons, M.F.6
  • 5
    • 33745713376 scopus 로고    scopus 로고
    • A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)
    • Silva M., Poo J., Wagner F., Jackson M., Cutler D., Grace M., et al. A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE). J Hepatol 45 (2006) 204-213
    • (2006) J Hepatol , vol.45 , pp. 204-213
    • Silva, M.1    Poo, J.2    Wagner, F.3    Jackson, M.4    Cutler, D.5    Grace, M.6
  • 6
    • 33144462713 scopus 로고    scopus 로고
    • Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
    • Diago M., Castellano G., Garcia-Samaniego J., Perez C., Fernandez I., Romero M., et al. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 55 (2006) 374-379
    • (2006) Gut , vol.55 , pp. 374-379
    • Diago, M.1    Castellano, G.2    Garcia-Samaniego, J.3    Perez, C.4    Fernandez, I.5    Romero, M.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.